Diabetes in Depth Melville, NY 2008 - December 10, 2008...

Diabetes in Depth Melville, NY 2008 - December 10, 2008 - Melville, NY

Diabetes in Depth Melville, NY 2008
December 10, 2008
Melville, NY

Meeting Overview
Venue: Melville Marriott Long IslandPrimary Audience: Primary CareCredits: 8.5 AMA Category 1, AAFP, 8.5 AANP

Diabetes In Depth

Diabetes In Depth is a continuing medical education program designed to meet the education and practice needs of clinicians who regularly diagnose and manage patients with diabetes. At every session, leading experts will provide world-class information on the cormorbidities and risk factors associated with what has become one of the greatest health problems. Earn up to 8.5 AMA PRA Category 1 Credit(s)TM or 8.5 AANP contact hours of continuing education, at no cost.

Program Objectives

Attend this continuing medical education activity and you will be able to:

Incorporate essential clinical management tools, including self-monitoring of blood glucose, medical nutritional therapy, and patient education.
Assess treatment strategies and implement patient-specific directed therapies.
Analyze the methods and role of intensive glycemic control through early intervention and treatment advancement.
Address multifactorial cardiovascular risk in the patient with diabetes, and strategies to manage cardiometabolic risk factors.
Explore emerging and new perspectives in the treatment of diabetes.


Curriculum Developed by Course Directors:

Ken Fujioka, MD, Division of Endocrinology & Diabetes, Director of the Nutrition and Metabolic Research Center, Scripps Clinic, La Jolla, CA
M. Sue Kirkman, MD, Vice President, Clinical Affairs, American Diabetes Association, Alexandria, VA




Complimentary Education Materials courtesy of the American Diabetes Association

Attend this program and you will receive important provider and patient materials from the American Diabetes Association that can help your patients understand the cardiometabolic risks associated with diabetes, and help them to better achieve their health goals.



This activity is intended for primary care providers currently engaged in patient care.


Special Needs

In accordance with the Americans with Disabilities Act, Pri-Med Institute seeks to make this conference accessible to all. If you have a need which might require special accommodations, please call 877-4PRI-MED or email support@pri-med.com three weeks prior to the meeting.

Marketing Partners
Pri-Med partners with local healthcare associations, managed care organizations, and publications in order to ensure that all practicing clinicians have the opportunity to attend. Pri-Med would like to thank the following partners for this program to date: Aetna, American Academy of Nurse Practitioners, and HIP Health Plan of New York and GHI.

Educational Grants
To date, the following organizations have provided educational grants in support of this Pri-Med activity: Abbott , Amylin Pharmaceuticals, Inc. and Eli Lilly and Company, Merck & Co., Inc., and Novo Nordisk Inc..
Session Topics
This live program consists of 5 case-based sessions and 3 workshops. Select sessions below offer related, accredited Online CME activities. Participate in the online CME activities before the live session to prepare in advance or after the lecture to learn more about the topic. At the live program each lecture will be followed by a 15-minute networking break and complimentary lunch will be provided.

View Schedule for:Wednesday (Dec - 10)Wednesday, December 10, 2008
8:00 AM-9:15 AM Prevention and Diagnosis of Type 2 Diabetes
Learning Objectives:
Identify the cascade of factors--including insulin resistance and impaired beta-cell function--that contribute to the pathophysiology of type 2 diabetes.
Detail the role of timely lifestyle changes and pharmacotherapy in the prevention of type 2 diabetes.
Louis Kuritzky, MD, (Read Bio) Clinical Assistant Professor, Department of Community Health and Family Medicine, University of Florida College of Medicine, Gainesville, FL
9:15 AM-10:30 AM The First Step: Managing Diabetes Through Noninsulin Therapy
Learning Objectives:
Outline the initial treatment options for managing type 2 diabetes in a newly diagnosed patient
Understand the parameters that guide when and how to step up pharmacotherapy in a patient who is not well controlled on monotherapy.
Howard A. Brand, MD, Medical Director, Sound Endocrinology, Stonybrook, NY
10:45 AM-11:30 AM Workshop 1: Assessment of Special Populations and Risk
Learning Objectives:
Recognize the degree to which ethnicity and age influence how patients approach the diagnosis and management of a chronic illness like diabetes
Apply culturally sensitive principles to diabetes care in Latino, African American, and Asian populations.
Howard A. Brand, MD, Medical Director, Sound Endocrinology, Stonybrook, NY
11:45 AM-1:00 PM Working Lunch: Insulin Therapy--Best Practices for Use
Learning Objectives:
Understand the strengths and limitations of the different types of insulin products, including rapid-acting analogs, intermediate- and long-acting insulins, and premixed insulins.
Discuss when and how to initiate insulin therapy in an insulin-naive patient.
Lawrence Blonde, MD, FACP, FACE, Director, Ochsner Diabetes Clinical Research Unit, Department of Endocrinology, Diabetes, and Metabolic Diseases, Ochsner Clinic Foundation, New Orleans, LA
1:15 PM-2:00 PM Workshop 2: Insulin Initiation and Intensification
Learning Objectives:
Develop skill in calculating and titrating insulin doses using basal and premixed insulin.
Sketch out a scenario that calls for appropriate insulin titration in a patient with type 2 diabetes.
Lawrence Blonde, MD, FACP, FACE, Director, Ochsner Diabetes Clinical Research Unit, Department of Endocrinology, Diabetes, and Metabolic Diseases, Ochsner Clinic Foundation, New Orleans, LA
2:00 PM-3:15 PM Dyslipidemia and Hypertension in the Diabetic Patient
Learning Objectives:
Understand the parameters that define the amplified risk posed by these common comorbidities in patients with type 2 diabetes
Apply the most current lipid and HTN management guidelines, with an eye on the specific goals in a patient with diabetes.
T. Barry Levine, MD, Professor of Medicine, Drexel University School of Medicine, Philadelphia, PA, Cheif Medical Officer, A.B.L.E. Medical Consulting, Inc., Pittsburgh, PA
3:30 PM-4:15 PM Workshop 3: Assessment and Management of the Diabetic Foot
Learning Objectives:
Understand how the complications and comorbidities of type 2 diabetes increase the risk of foot ulcers.
Learn how to do a comprehensive foot exam and identify "red flags" that warrant referral in high-risk patients.
Emily A. Cook, DPM, Harvard School of Public Health, Boston, MA, Clinical Instructor in Surgery, Harvard Medical School, Boston, MA, Harvard Podiatric Reconstruction & Research Fellowship, Beth Isreal Deaconess Medical Center, Boston, MA
4:15 PM-5:30 PM New Perspectives in the Management of Obesity
Learning Objectives:
Understand how obesity complicates the management of type 2 diabetes and compounds the risk of cardiovascular disease.
Detail the initial and "next step" treatment options in managing obesity in your type 2 diabetes patients.
Holly Wyatt, MD, Center for Human Nutrition, University of Colorado Health Sciences Center, Aurora, CO
Accreditation

Credits Type Accreditation Statement Designation Statement
8.5 AMA Category 1 Pri-Med Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Pri-Med Institute designates this educational activity for a maximum of 8.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Pending AAFP Application for CME credit has been filed with American Academy of Family Physicians. Determination of credit is pending.
8.5 AANP Pri-Med Institute is approved as a provider of nurse practitioner continuing education programs by the American Academy of Nurse Practitioners. AANP Provider number 040308. This program has been approved for 8.5 contact hour of continuing education , which includes 4.250 hours of pharmacology.


Academic Partner
Pri-Med Institute gratefully acknowledges the University of Wisconsin School of Medicine and Public Health and Tufts Health Care Institute for serving as academic partners in the review of educational content.

Statement of Independence
This educational program is conceived and credited in accordance with ACCME’s Essential Areas and Policies, including the 2004 Updated Standards for Commercial Support. Pri-Med faculty hail from a variety of institutions and participate in content development, along with Pri-Med Institute’s Advisory Boards and its expert review partners, the University of Wisconsin School of Medicine and Public Health and Tufts Health Care Institute. All final decisions about program content are the responsibility of Pri-Med Institute.

Meeting Location
Melville Marriott Long Island
1350 Old Walt Whitman Rd
Melville, NY 11747
(800)228-9290
Hotel Accommodations
A limited number of rooms have been reserved at the Melville Marriott Long Island. Please call (800)228-9290 by 11/19/2008 and identify yourself as a Diabetes In Depth attendee to receive the discounted rate of $179.

Meeting Resources
Downloadable session slides are not available for Diabetes In Depth meetings. A printed syllabus will be provided on-site.

Pri-Med
c/o M|C Communications, LLC
101 Huntington Ave.
Boston, MA 02199-7607